fda compounding semaglutide enforcement november 2025 news September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Diabetes advocacy group discourages use

Lipo-B injections are an all-natural injection of essential amino acids, minerals, and vitamins that support liver function and overall health

Exendin-4 is a high potency agonist and truncated exendin-(939)-amide an antagonist at the glucagon-like peptide 1-(736)-amide receptor of insulin-secreting -cells

Gallbladder issues: Rapid weight loss can increase risk for gallstones

Opportunities in the GLP-1 analogues market are abundant, particularly in expanding therapeutic applications, strategic collaborations, mergers, and acquisitions are reshaping the competitive landscape, while the increasing acceptance of GLP-1 therapies for chronic weight management is opening new revenue streams

The area postrema is the key non-overlapping target retatrutide does not appreciably engage it